Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

NCT06320405 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Recurrent Malignant Solid Neoplasm
Refractory Malignant Solid Neoplasm

Interventions

BIOLOGICAL: Axatilimab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Paclitaxel
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Retifanlimab

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]